Merck announced recently that patients have filled two million prescriptions for its new diabetes drug Januvia. Wall Street Journal "Diabetes Drug Wins New UsesIt also announced that new and potentially worrisome side effects have turned up, all relating to the immune system, including rashes and swelling and one potentially fatal condition, Stevens-Johnson syndrome, where the skin literally
